Clinical trials: Purpura
IgA Vasculitis
Evaluation of Glucocorticoids Plus Rituximab in Patients With Newly-Diagnosed or Relapsing IgA Vasculitis
Systemic vasculitis are inflammatory diseases of the blood vessels, responsible for systemic manifestations. Among the systemic vasculitis affecting small blood vessels, IgA vasculitis (IgAV) is one of the most common forms and…
- Trial name
- RIGA (NCT05329090)
- Testing
- Rituximab Injection
- Where
- 14 sites in France
- Volunteers
- 75 people
- Sponsor
- Hopital Foch
ITP, Croticosteroid Therapy
Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
In this prospective, randomized, controlled clinical trial investigators' aim was to compare the efficacy and the adverse effect of 3 therapy cycles of HD-DXM versus conventional treatment with PDN for untreated adult patients…
- Trial name
- NCT02914054
- Testing
- High dose Dexamethasone pulses, Prednisone
- Where
- Iran
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Isfahan University of Medical Sciences
Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
With conventional treatments (i.e. iv Ig, steroids) the overall response rate of ITP secondary to LPD is generally lower than in primary ITP, and usually not higher than 50% (95% CI 27-72).
- Conditions
- Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Autoimmune Thrombocytopenia, Chronic Lymphocytic Leukemia
- Trial name
- NCT01610180
- Testing
- Eltrombopag Olamine
- Where
- Italy
- Volunteers
- 18 people
- Sponsor
- Fondazione Progetto Ematologia